Legacy Financial Strategies’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Buy
844
+63
+8% +$64.4K 0.16% 62
2026
Q1
$719K Buy
781
+18
+2% +$18.2K 0.13% 68
2025
Q4
$820K Buy
763
+8
+1% +$7.65K 0.15% 67
2025
Q3
$576K Sell
755
-44
-6% -$32.7K 0.1% 75
2025
Q2
$623K Buy
799
+71
+10% +$55.2K 0.12% 69
2025
Q1
$602K Buy
728
+43
+6% +$35.8K 0.13% 64
2024
Q4
$533K Sell
685
-80
-10% -$66.2K 0.11% 72
2024
Q3
$678K Buy
765
+50
+7% +$45K 0.15% 61
2024
Q2
$642K Buy
715
+21
+3% +$16.8K 0.15% 60
2024
Q1
$540K Buy
694
+61
+10% +$43.4K 0.14% 57
2023
Q4
$369K Hold
633
0.11% 60
2023
Q3
$392K Hold
633
0.13% 57
2023
Q2
$297K Sell
633
-41
-6% -$17.2K 0.1% 61
2023
Q1
$232K Hold
674
0.09% 67
2022
Q4
$247K Buy
674
+41
+6% +$14.5K 0.1% 60
2022
Q3
$205K Hold
633
0.1% 61
2022
Q2
$205K Buy
+633
New +$190K 0.1% 61

Other funds holding LLY

Legacy Financial Strategies's LLY Position: Q2 2026 in Review

Legacy Financial Strategies increased its Eli Lilly (LLY) stake by 8.1% in Q2 2026, buying an estimated $64.4K and bringing the position to 844 shares worth $1.01M. The position accounts for 0.16% of the portfolio, ranked #62.

Legacy Financial Strategies first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 1,793 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legacy Financial Strategies held 844 shares of Eli Lilly worth $1.01M as of Q2 2026.
  • Legacy Financial Strategies bought 63 Eli Lilly shares in Q2 2026, an estimated $64.4K.
  • Eli Lilly made up 0.16% of Legacy Financial Strategies's portfolio in Q2 2026, its #62 holding.
  • Legacy Financial Strategies first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 1,793 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legacy Financial Strategies's 13F filing for Q2 2026, filed 21 Jul 2026.